Search Page
Filters
Results by year
Table representation of search results timeline featuring number of search results per year.
Year | Number of Results |
---|---|
1983 | 1 |
1986 | 1 |
2002 | 1 |
2003 | 2 |
2005 | 3 |
2006 | 3 |
2007 | 1 |
2008 | 1 |
2009 | 1 |
2010 | 5 |
2011 | 6 |
2012 | 2 |
2013 | 10 |
2014 | 9 |
2015 | 12 |
2016 | 7 |
2017 | 9 |
2018 | 7 |
2019 | 7 |
2020 | 6 |
2021 | 6 |
2022 | 7 |
2023 | 8 |
2024 | 4 |
Search Results
104 results
Results by year
They also had lower mean Charlson Comorbidity Index (CCI) scores (1.99 vs. 2.70; P < 0.001), fewer OAB-related comorbidities, fewer concomitant medications (P < 0.005), and fewer overall prescriptions dispensed in the previous 12 months (P < 0.001) c
…They also had lower mean Charlson Comorbidity Index (CCI) scores (1.99 vs. 2.70; P < 0.001), fewer OAB-related comorbidities, fewe
…RESULTS: Of 194,511 patients, trends in utilization of OAB medications indicated that on average, there was a statistically significant monthly increase in utilization of mirabegron (regression coefficient [B] = 274; P < 0.001; 95% CI: 218, 330), fesoterodine (B = 167;
…Compared to the clinical cohort, pathology-confirmed rpAD had higher frequencies of apolipoprotein E (APOE) epsilon4 and rare missense variants in AD risk genes. A novel genome-wide significant locus (P < 510(-8) ) was observed for clinical rpAD on chromosome 21 (rs2832
…